Abstract
Prenatal screening and diagnosis are major methods for control of birth defects, which is a very important problem in China. Here, we review current situation and development of prenatal screening and diagnosis in mainland China, including prenatal screening and prenatal diagnosis of fetal chromosome abnormalities, non-invasive prenatal diagnostic techniques and prenatal diagnosis of monogenic diseases, polygenic disease and congenital metabolic diseases. We also discuss epidemiology of birth defects and genetic diseases in China and related ethical issues of prenatal diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bian XM, Liu J T, Qi Q W, Jiang Y L, Li Y, Liu S Y, Hao N, Zhou J, Lü SM, Zhu B S, Wang H, Xu Z F, Pan X Y, Liao C, Cai Y, Wang H, Wang Z, Zhu J, Hu Y L. Second trimester maternal serum screening for Down’s syndrome in mainland China: a multi-center prospective study. Zhonghua Fu Chan Ke Za Zhi, 2008, 43(11): 805–809 (in Chinese)
Cowans N J, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn, 2007, 27(3): 264–271
Wald N J, Rodeck C, Hackshaw A K, Rudnicka A. SURUSS in perspective. BJOG, 2004, 111(6): 521–531
Malone F D, Canick J A, Ball R H, Nyberg D A, Comstock C H, Bukowski R, Berkowitz R L, Gross S J, Dugoff L, Craigo S D, Timor-Tritsch I E, Carr S R, Wolfe H M, Dukes K, Bianchi D W, Rudnicka A R, Hackshaw A K, Lambert-Messerlian G, Wald N J, D’Alton M E; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down’s syndrome. New Engl J Med, 2005, 353(19): 2001–2011
Poon L L, Leung T N, Lau T K, Chow K C, Lo Y M D. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem, 2002, 48(1): 35–41
Li L, Zhou Y Q, Xiao Q Z, Yan T Z, Xu X M. Development and evaluation of a reverse dot blot assay for the simultaneous detection of six common Chinese G6PD mutations and one polymorphism. Blood Cells Mol Dis, 2008, 41(1): 17–21
Yi P, Yu F, Huang S, Zhong C, Li Q, Yang Y, Zhang W, Xiao C, Xu X. Identification of a novel frameshift mutation at codon 53 (-T) in the beta-globin gene causing dominantly inherited beta-thalassemia in a Chinese Miao family. Blood Cells Mol Dis, 2008, 41(1): 56–59
Zeng F, Ren Z R, Huang S Z, Kalf M, Mommersteeg M, Smit M, White S, Jin C L, Xu M, Zhou D W, Yan J B, Chen M J, van Beuningen R, Huang S Z, den Dunnen J, Zeng Y T, Wu Y. Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients. Hum Mutat, 2008, 29(1): 190–197
Yin S, Na Q, Chen J, Li-Ling J, Liu C. Contribution of MRI to detect further anomalies in fetal ventriculomegaly. Fetal Diagn Ther, 2010, 27(1): 20–24
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bian, XM., Guo, Q. & Qi, QW. Current situation and development of prenatal diagnosis in China. Front. Med. China 4, 271–274 (2010). https://doi.org/10.1007/s11684-010-0100-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-010-0100-z